Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone with GnRH analog in castration-resistant prostate cancer
2010-022010-32Phase 2Completed
- Sponsor
- Barts Health NHS Trust
- Start
- May 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of triamcinolone in prostate cancer (PCa), sponsored by Barts Health NHS Trust. Primary endpoint: Progression-free survival. Started May 2011; status: completed.
02
Drugs
triamcinolone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on 2010-022010-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022010-32.